Lexaria Bioscience Corp. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Blue Water Biotech, Inc.

Sunshine Biopharma, Inc.

Cyclerion Therapeutics, Inc.

Talphera, Inc.

Neurosense Therapeutics Ltd.

Lexaria Bioscience Corp.

Theriva Biologics, Inc.

Shuttle Pharmaceuticals Holdings, Inc.

Trevena, Inc.

Timber Pharmaceuticals, Inc.

Comera Life Sciences Holdings, Inc.

Why is Lexaria Bioscience Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Lexaria Bioscience Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Lexaria Bioscience Corp.

-45.98%

-0.80

104.70%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.66%

EBIT Growth (5y)

-190.44%

EBIT to Interest (avg)

-6.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.83

Sales to Capital Employed (avg)

0.09

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

16.27%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.76

EV to EBIT

-1.33

EV to EBITDA

-1.34

EV to Capital Employed

14.08

EV to Sales

14.08

PEG Ratio

Dividend Yield

ROCE (Latest)

-1054.98%

ROE (Latest)

-214.71%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING PROFIT(Q)

Highest at USD -1.43 MM

PRE-TAX PROFIT(Q)

Highest at USD -1.45 MM

NET PROFIT(Q)

Highest at USD -1.45 MM

EPS(Q)

Highest at USD -0.06

-9What is not working for the Company

NET SALES(HY)

At USD 0.02 MM has Grown at -94.41%

RAW MATERIAL COST(Y)

Grown by 138.13% (YoY

Here's what is working for Lexaria Bioscience Corp.

Operating Profit

Highest at USD -1.43 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -1.45 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -1.45 MM has Grown at 45%

over average net sales of the previous four periods of USD -2.64 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -1.45 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit

At USD -1.45 MM has Grown at 44.97%

over average net sales of the previous four periods of USD -2.63 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.06

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Lexaria Bioscience Corp.

Net Sales

At USD 0.02 MM has Grown at -94.41%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Raw Material Cost

Grown by 138.13% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales